Posts
www.latimes.com
An experimental drug called ONO-4641 reduced the number of lesions in patients with relapsing-remitting multiple sclerosis by as much as 92%, Colorado researchers reported Tuesday. The drug must undergo a larger clinical trial before it can be approved for general use, but the early results sugges...
1 comment:
Always these new oral drugs for MS, neglecting the fact that there has been an extremely effective, inexpensive and very safe oral drug treatment for almost two decades now: low dose naltrexone. It tends to work even better in MS than CFS/ME, but the patients have the same problem as we CFS/ME patients do with the dozens of good treatments already available: many of them can't get it. What a disgrace!
Post a Comment